{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:37:41Z","timestamp":1791110261990,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The development of new natural drugs for <jats:italic>Helicobacter pylori<\/jats:italic> (<jats:italic>H. pylori<\/jats:italic>) management has recently received significant attention. <jats:italic>Iris confusa<\/jats:italic> (<jats:italic>I. confusa<\/jats:italic>) was long used for the treatment of bacterial infections and gastritis. This study aimed at evaluating its effect on management of <jats:italic>H. pylori<\/jats:italic> infection and exploring its bioactive metabolites. The inhibitory potential of the polar (PF), non-polar (NPF) fractions and the isolated compounds against <jats:italic>H. pylori<\/jats:italic> using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay in addition to their cyclooxygenases (COX-1 and COX-2), and nitric oxide (NO) inhibitory activities were assessed. The most biologically active compound was tested for its selective <jats:italic>H. pylori<\/jats:italic> inosine-5\u2032-monophosphate dehydrogenase (<jats:italic>Hp<\/jats:italic>IMPDH) inhibitory potential. Chromatographic purification of PF and NPF allowed isolation of tectoridin, orientin, irigenin, tectorigenin, isoarborinol and stigmasterol. The PF exhibited significant anti-<jats:italic>H. pylori<\/jats:italic> (MIC 62.50\u00a0\u00b5g\/mL)<jats:italic>,<\/jats:italic> COX-1, COX-2 (IC<jats:sub>50<\/jats:sub> of 112.08\u2009\u00b1\u20090.60 and 47.90\u2009\u00b1\u20091.50\u00a0\u00b5g\/mL respectively, selectivity index SI of 2.34), and NO (IC<jats:sub>50<\/jats:sub> 47.80\u2009\u00b1\u20090.89\u00a0\u00b5g\/mL) inhibitory activities, while irigenin was the most potent isolated compound. Irigenin was found to have a promising activity against <jats:italic>Hp<\/jats:italic>IMPDH enzyme (IC<jats:sub>50<\/jats:sub> of 2.07\u2009\u00b1\u20091.90\u00a0\u03bcM) with low activity against human <jats:italic>h<\/jats:italic>IMPDH2 (IC<jats:sub>50<\/jats:sub>\u2009&gt;\u200910\u00a0\u03bcM) than clarithromycin, assuring its selectivity. Overall, <jats:italic>I. confusa<\/jats:italic> and its isolated compounds may serve as a potential source of plant-based drugs for <jats:italic>H. pylori<\/jats:italic> control. This study scientifically validated the claimed anti-bacterial activity of <jats:italic>I. confusa<\/jats:italic> and revealed irigenin potential as a novel lead exhibiting anti <jats:italic>H. pylori<\/jats:italic> activity in a first record.<\/jats:p>","DOI":"10.1038\/s41598-022-15361-w","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T20:06:58Z","timestamp":1657138018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Irigenin, a novel lead from Iris confusa for management of Helicobacter pylori infection with selective COX-2 and HpIMPDH inhibitory potential"],"prefix":"10.1038","volume":"12","author":[{"given":"Passent M.","family":"Abdel-Baki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshera M.","family":"El-Sherei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal E.","family":"Khaleel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-8123","authenticated-orcid":false,"given":"Mona M.","family":"Okba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"15361_CR1","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.phymed.2005.06.008","volume":"13","author":"P Stege","year":"2006","unstructured":"Stege, P. et al. Antimicrobial activity of aqueous extracts of Larrea divaricata Cav (jarilla) against Helicobacter pylori. Phytomedicine 13, 724\u2013727 (2006).","journal-title":"Phytomedicine"},{"key":"15361_CR2","doi-asserted-by":"publisher","first-page":"G791","DOI":"10.1152\/ajpgi.2000.279.4.G791","volume":"279","author":"S Takahashi","year":"2000","unstructured":"Takahashi, S., Fujita, T. & Yamamoto, A. Role of cyclooxygenase-2 in Helicobacter pylori-induced gastritis in Mongolian gerbils. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G791\u2013G798 (2000).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"15361_CR3","unstructured":"Hoffman, J. in Seminars in Gastrointestinal Disease 156\u2013163."},{"key":"15361_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1523-5378.2005.00327.x","volume":"10","author":"GM Matthews","year":"2005","unstructured":"Matthews, G. M. & Butler, R. N. Cellular mucosal defense during Helicobacter pylori infection: A review of the role of glutathione and the oxidative pentose pathway. Helicobacter 10, 298\u2013306 (2005).","journal-title":"Helicobacter"},{"key":"15361_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fmicb.2018.00005","volume":"9","author":"P D\u00edaz","year":"2018","unstructured":"D\u00edaz, P., Valenzuela Valderrama, M., Bravo, J. & Quest, A. F. Helicobacter pylori and gastric cancer: Adaptive cellular mechanisms involved in disease progression. Front. Microbiol. 9, 5 (2018).","journal-title":"Front. Microbiol."},{"key":"15361_CR6","unstructured":"IARC. in Schistosomes, Liver Flukes and Helicobacter pylori 218\u2013220 (1994)."},{"key":"15361_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrc703","volume":"2","author":"RM Peek","year":"2002","unstructured":"Peek, R. M. & Blaser, M. J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2, 28\u201337 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"15361_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/00001574-199611000-00003","volume":"12","author":"JL Wallace","year":"1996","unstructured":"Wallace, J. L. & Bell, C. J. Gastroduodenal mucosal defense. Curr. Opin. Gastroenterol. 12, 503\u2013511 (1996).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"15361_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0005-2760(95)00194-8","volume":"1299","author":"HR Herschman","year":"1996","unstructured":"Herschman, H. R. Prostaglandin synthase 2. Biochim. Biophys. Acta (BBA) Lipids Lipid Metab. 1299, 125\u2013140 (1996).","journal-title":"Biochim. Biophys. Acta (BBA) Lipids Lipid Metab."},{"key":"15361_CR10","first-page":"147","volume-title":"COX-2 Blockade in Cancer Prevention and Therapy","author":"R Langenbach","year":"2003","unstructured":"Langenbach, R. COX-2 Blockade in Cancer Prevention and Therapy 147\u2013155 (Springer, 2003)."},{"key":"15361_CR11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","volume":"63","author":"L Minghetti","year":"2004","unstructured":"Minghetti, L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 63, 901\u2013910 (2004).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"15361_CR12","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.1038\/sj.bjp.0706400","volume":"147","author":"S Lucas","year":"2006","unstructured":"Lucas, S., Rothwell, N. & Gibson, R. The role of inflammation in CNS disease and injury. Br. J. Pharmacol. 147, S232\u2013S240 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"15361_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.molmed.2008.08.005","volume":"14","author":"H Harizi","year":"2008","unstructured":"Harizi, H., Corcuff, J.-B. & Gualde, N. Arachidonic-acid-derived eicosanoids: Roles in biology and immunopathology. Trends Mol. Med. 14, 461\u2013469 (2008).","journal-title":"Trends Mol. Med."},{"key":"15361_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama, H. et al. Inflammation and Alzheimer\u2019s disease. Neurobiol. Aging 21, 383\u2013421 (2000).","journal-title":"Neurobiol. Aging"},{"key":"15361_CR15","first-page":"209","volume":"6","author":"K Krysan","year":"2006","unstructured":"Krysan, K., Reckamp, K. L., Sharma, S. & Dubinett, S. M. The potential and rationale for COX-2 inhibitors in lung cancer. Anti-Cancer Agents Med. Chem. (Formerly Curr. Med. Chem. Anti-Cancer Agents) 6, 209\u2013220 (2006).","journal-title":"Anti-Cancer Agents Med. Chem. (Formerly Curr. Med. Chem. Anti-Cancer Agents)"},{"key":"15361_CR16","first-page":"198","volume":"59","author":"KC Zimmermann","year":"1999","unstructured":"Zimmermann, K. C. et al. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 59, 198\u2013204 (1999).","journal-title":"Cancer Res."},{"key":"15361_CR17","first-page":"1923","volume":"7","author":"K Saukkonen","year":"2001","unstructured":"Saukkonen, K. et al. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma. Clin. Cancer Res. 7, 1923\u20131931 (2001).","journal-title":"Clin. Cancer Res."},{"key":"15361_CR18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/sj.bjp.0701672","volume":"123","author":"A Schmassmann","year":"1998","unstructured":"Schmassmann, A. et al. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br. J. Pharmacol. 123, 795\u2013804 (1998).","journal-title":"Br. J. Pharmacol."},{"key":"15361_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s100670070024","volume":"19","author":"B Everts","year":"2000","unstructured":"Everts, B., W\u00e4hrborg, P. & Hedner, T. COX-2-Specific inhibitors\u2014The emergence of a new class of analgesic and anti-inflammatory drugs. Clin. Rheumatol. 19, 331\u2013343 (2000).","journal-title":"Clin. Rheumatol."},{"key":"15361_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten, F. R. & Grivennikov, S. I. Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity 51, 27\u201341 (2019).","journal-title":"Immunity"},{"key":"15361_CR21","volume":"2019","author":"RS Wong","year":"2019","unstructured":"Wong, R. S. Role of nonsteroidal anti-inflammatory drugs (NSAIDs) in cancer prevention and cancer promotion. Adv. Pharmacol. Sci. 2019, 3418975 (2019).","journal-title":"Adv. Pharmacol. Sci."},{"key":"15361_CR22","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","volume":"96","author":"TD Warner","year":"1999","unstructured":"Warner, T. D. et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc. Natl. Acad. Sci. 96, 7563\u20137568 (1999).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"15361_CR23","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3389\/fphar.2018.00976","volume":"9","author":"A Attiq","year":"2018","unstructured":"Attiq, A., Jalil, J., Husain, K. & Ahmad, W. Raging the war against inflammation with natural products. Front. Pharmacol. 9, 976 (2018).","journal-title":"Front. Pharmacol."},{"key":"15361_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/00001574-200101000-00006","volume":"17","author":"JS Hoffman","year":"2001","unstructured":"Hoffman, J. S. & Cave, D. R. Treatment of Helicobacter pylori. Curr. Opin. Gastroenterol. 17, 30\u201334. https:\/\/doi.org\/10.1097\/00001574-200101000-00006 (2001).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"15361_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.0306-5251.2001.01220.x","volume":"53","author":"L Mellemkjaer","year":"2002","unstructured":"Mellemkjaer, L. et al. Upper gastrointestinal bleeding among users of NSAIDs: A population-based cohort study in Denmark. Br. J. Clin. Pharmacol. 53, 173\u2013181. https:\/\/doi.org\/10.1046\/j.0306-5251.2001.01220.x (2002).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"15361_CR26","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/s0140-6736(94)90185-6","volume":"343","author":"MJ Langman","year":"1994","unstructured":"Langman, M. J. et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 343, 1075\u20131078. https:\/\/doi.org\/10.1016\/s0140-6736(94)90185-6 (1994).","journal-title":"Lancet"},{"key":"15361_CR27","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.3390\/ijerph17103376","volume":"17","author":"E Salmer\u00f3n-Manzano","year":"2020","unstructured":"Salmer\u00f3n-Manzano, E., Garrido-Cardenas, J. A. & Manzano-Agugliaro, F. Worldwide research trends on medicinal plants. Int. J. Environ. Res. Public Health 17, 3376 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"15361_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5937\/bnhmb1811189N","volume":"11","author":"M Niketi\u0107","year":"2018","unstructured":"Niketi\u0107, M., Tomovi\u0107, G. & Siljak-Yakovlev, S. A new spontaneous hybrid between the cultivated and wild Iris species from Serbia. Bull. Nat. His. Museum 11, 189\u2013210 (2018).","journal-title":"Bull. Nat. His. Museum"},{"key":"15361_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114658","volume":"282","author":"MM Okba","year":"2022","unstructured":"Okba, M. M. et al. UPLC-ESI-MS\/MS profiling of the underground parts of common Iris species in relation to their anti-virulence activities against Staphylococcus aureus. J. Ethnopharmacol. 282, 114658 (2022).","journal-title":"J. Ethnopharmacol."},{"key":"15361_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/antibiotics9070403","volume":"9","author":"L Hoang","year":"2020","unstructured":"Hoang, L. et al. Phytochemical composition and in vitro biological activity of Iris spp. (Iridaceae): A new source of bioactive constituents for the inhibition of oral bacterial biofilms. Antibiotics 9, 403 (2020).","journal-title":"Antibiotics"},{"key":"15361_CR31","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1248\/cpb.49.1295","volume":"49","author":"MI Choudhary","year":"2001","unstructured":"Choudhary, M. I. et al. Five new peltogynoids from underground parts of Iris bungei: A Mongolian medicinal plant. Chem. Pharm. Bull. 49, 1295\u20131298 (2001).","journal-title":"Chem. Pharm. Bull."},{"key":"15361_CR32","first-page":"24","volume":"24","author":"I Crisan","year":"2016","unstructured":"Crisan, I. & Cantor, M. New perspectives on medicinal properties and uses of Iris sp. Hop. Med. Plants 24, 24\u201336 (2016).","journal-title":"Hop. Med. Plants"},{"key":"15361_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2307\/25065592","volume":"55","author":"J Ma","year":"2006","unstructured":"Ma, J. & Clemants, S. A history and overview of the Flora Reipublicae Popularis Sinicae (FRPS, Flora of China, Chinese edition, 1959\u20132004). Taxon 55, 451\u2013460 (2006).","journal-title":"Taxon"},{"key":"15361_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.fitote.2018.06.005","volume":"129","author":"X Chen","year":"2018","unstructured":"Chen, X. et al. Iridal-type triterpenoids with anti-HBV activity from Iris confusa. Fitoterapia 129, 126\u2013132 (2018).","journal-title":"Fitoterapia"},{"key":"15361_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/pca.2945","volume":"32","author":"MM Okba","year":"2021","unstructured":"Okba, M. M., Abdel Baki, P. M., Khaleel, A. E., El-Sherei, M. M. & Salem, M. A. Discrimination of common Iris species from Egypt based on their genetic and metabolic profiling. Phytochem. Anal. 32, 172\u2013182 (2021).","journal-title":"Phytochem. Anal."},{"key":"15361_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13007-016-0146-2","volume":"12","author":"MA Salem","year":"2016","unstructured":"Salem, M. A., J\u00fcppner, J., Bajdzienko, K. & Giavalisco, P. Protocol: A fast, comprehensive and reproducible one-step extraction method for the rapid preparation of polar and semi-polar metabolites, lipids, proteins, starch and cell wall polymers from a single sample. Plant Methods 12, 1\u201315 (2016).","journal-title":"Plant Methods"},{"key":"15361_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6882-9-2","volume":"9","author":"C Bonacorsi","year":"2009","unstructured":"Bonacorsi, C., Raddi, M. S. G., Carlos, I. Z., Sannomiya, M. & Vilegas, W. Anti-Helicobacter pylori activity and immunostimulatory effect of extracts from Byrsonima crassa Nied. (Malpighiaceae). BMC Complement. Altern. Med. 9, 1\u20137 (2009).","journal-title":"BMC Complement. Altern. Med."},{"key":"15361_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/1472-6882-14-355","volume":"14","author":"A George","year":"2014","unstructured":"George, A. et al. Anti-inflammatory effects of Polygonum minus (Huds) extract (Lineminus\u2122) in in-vitro enzyme assays and carrageenan induced paw edema. BMC Complement. Altern. Med. 14, 355. https:\/\/doi.org\/10.1186\/1472-6882-14-355 (2014).","journal-title":"BMC Complement. Altern. Med."},{"key":"15361_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/10826068.2012.697958","volume":"43","author":"C Chantaranothai","year":"2013","unstructured":"Chantaranothai, C., Palaga, T., Karnchanatat, A. & Sangvanich, P. Inhibition of nitric oxide production in the macrophage-like RAW 264.7 cell line by protein from the rhizomes of Zingiberaceae plants. Prep. Biochem. Biotechnol. 43, 60\u201378 (2013).","journal-title":"Prep. Biochem. Biotechnol."},{"key":"15361_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202000385","volume":"354","author":"AM Galal","year":"2021","unstructured":"Galal, A. M., Mohamed, H. S., Abdel-Aziz, M. M. & Hanna, A. G. Development, synthesis, and biological evaluation of sulfonyl-\u03b1-L-amino acids as potential anti-Helicobacter pylori and IMPDH inhibitors. Arch. Pharm. 354, e2000385 (2021).","journal-title":"Arch. Pharm."},{"key":"15361_CR41","unstructured":"Druckerei, C. European Pharmacopoeia 4th edn (2002)."},{"key":"15361_CR42","first-page":"254","volume":"2","author":"M Kiranmai","year":"2011","unstructured":"Kiranmai, M., Kumar, C. M. & Mohammed, I. Comparison of total flavanoid content of Azadirachta indica root bark extracts prepared by different methods of extraction. Res. J. Pharm. Biol. Chem. Sci. 2, 254\u2013261 (2011).","journal-title":"Res. J. Pharm. Biol. Chem. Sci."},{"key":"15361_CR43","doi-asserted-by":"crossref","unstructured":"Chang, C. L., Lin, C. S. & Lai, G. H. Phytochemical characteristics, free radical scavenging activities, and neuroprotection of five medicinal plant extracts. Evid. Based Complement. Alternat. Med. 2012 (2012).","DOI":"10.1155\/2012\/984295"},{"key":"15361_CR44","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.foodchem.2008.12.029","volume":"115","author":"CS Romano","year":"2009","unstructured":"Romano, C. S., Abadi, K., Repetto, V., Vojnov, A. A. & Moreno, S. Synergistic antioxidant and antibacterial activity of rosemary plus butylated derivatives. Food Chem. 115, 456\u2013461 (2009).","journal-title":"Food Chem."},{"key":"15361_CR45","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/BF02975425","volume":"27","author":"ANB Singab","year":"2004","unstructured":"Singab, A. N. B. Flavonoids from Iris spuria (Zeal) cultivated in Egypt. Arch. Pharm. Res. 27, 1023\u20131028 (2004).","journal-title":"Arch. Pharm. Res."},{"key":"15361_CR46","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1590\/S0102-695X2013005000061","volume":"23","author":"DM de Oliveira","year":"2013","unstructured":"de Oliveira, D. M., Siqueira, E. P., Nunes, Y. R. & Cota, B. B. Flavonoids from leaves of Mauritia flexuosa. Rev. Bras. Farmacogn. 23, 614\u2013620 (2013).","journal-title":"Rev. Bras. Farmacogn."},{"key":"15361_CR47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/pca.1379","volume":"23","author":"B Roger","year":"2012","unstructured":"Roger, B., Jeannot, V., Fernandez, X., Cerantola, S. & Chahboun, J. Characterisation and quantification of flavonoids in Iris germanica L. and Iris pallida Lam. resinoids from Morocco. Phytochem. Anal. 23, 450\u2013455 (2012).","journal-title":"Phytochem. Anal."},{"key":"15361_CR48","doi-asserted-by":"publisher","first-page":"703","DOI":"10.26538\/tjnpr\/v4i10.8","volume":"4","author":"PQD Nguyen","year":"2020","unstructured":"Nguyen, P. Q. D. et al. In vitro cytotoxic activity of constituents of the aerial parts of Glycosmis parviflora. Trop. J. Nat. Prod. Res. 4, 703\u2013707 (2020).","journal-title":"Trop. J. Nat. Prod. Res."},{"key":"15361_CR49","first-page":"59","volume":"7","author":"YC Koay","year":"2013","unstructured":"Koay, Y. C., Wong, K. C., Osman, H., Eldeen, I. & Asmawi, M. Z. Chemical constituents and biological activities of Strobilanthes crispus L. Rec. Nat. Prod. 7, 59\u201364 (2013).","journal-title":"Rec. Nat. Prod."},{"key":"15361_CR50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.20307\/nps.2015.21.4.282","volume":"21","author":"W Park","year":"2015","unstructured":"Park, W. et al. Anti-Helicobacter pylori compounds from Maackia amurensis. Nat. Prod. Sci. 21, 49\u201353 (2015).","journal-title":"Nat. Prod. Sci."},{"key":"15361_CR51","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1039\/D1FO00226K","volume":"12","author":"B Kr\u00f3l-Kogus","year":"2021","unstructured":"Kr\u00f3l-Kogus, B., G\u0142\u00f3d, D., Ha\u0142asa, R., Krauze-Baranowska, M. & Pob\u0142ocka-Olech, L. 2D LC as a tool for standardization of Foenugraeci semen extracts containing compounds with anti-Helicobacter pylori activity. Food Funct. 12, 2686\u20132692. https:\/\/doi.org\/10.1039\/D1FO00226K (2021).","journal-title":"Food Funct."},{"key":"15361_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1053\/gast.1997.v112.pm9024292","volume":"112","author":"H Mizuno","year":"1997","unstructured":"Mizuno, H. et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112, 387\u2013397 (1997).","journal-title":"Gastroenterology"},{"key":"15361_CR53","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1089-8603(03)00032-6","volume":"8","author":"F Aktan","year":"2003","unstructured":"Aktan, F., Henness, S., Roufogalis, B. D. & Ammit, A. J. Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-\u03baB-mediated iNOS protein expression. Nitric Oxide 8, 235\u2013242 (2003).","journal-title":"Nitric Oxide"},{"key":"15361_CR54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1365-2249.1998.00648.x","volume":"113","author":"K Kr\u00f6ncke","year":"1998","unstructured":"Kr\u00f6ncke, K., Fehsel, K. & Kolb-Bachofen, V. Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 113, 147\u2013156 (1998).","journal-title":"Clin. Exp. Immunol."},{"key":"15361_CR55","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1073\/pnas.86.9.3375","volume":"86","author":"D Rees","year":"1989","unstructured":"Rees, D., Palmer, R. M. & Moncada, S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A. 86, 3375\u20133378 (1989).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"15361_CR56","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/med.21636","volume":"40","author":"R Minhas","year":"2020","unstructured":"Minhas, R., Bansal, Y. & Bansal, G. Inducible nitric oxide synthase inhibitors: A comprehensive update. Med. Res. Rev. 40, 823\u2013855 (2020).","journal-title":"Med. Res. Rev."},{"key":"15361_CR57","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4155\/fmc.15.72","volume":"7","author":"CP Shah","year":"2015","unstructured":"Shah, C. P. & Kharkar, P. S. Inosine 5\u2032-monophosphate dehydrogenase inhibitors as antimicrobial agents: Recent progress and future perspectives. Future Med. Chem. 7, 1415\u20131429 (2015).","journal-title":"Future Med. Chem."},{"key":"15361_CR58","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1080\/14786419.2015.1057585","volume":"30","author":"F Ullah","year":"2015","unstructured":"Ullah, F. et al. Phenolic, flavonoid contents, anticholinesterase and antioxidant evaluation of Iris germanica var. florentina. Nat. Prod. Res. 30, 1440\u20131444 (2015).","journal-title":"Nat. Prod. Res."},{"key":"15361_CR59","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1055\/s-2003-39698","volume":"69","author":"MP Montilla","year":"2003","unstructured":"Montilla, M. P. et al. Antioxidant activity of maslinic acid, a triterpene derivative obtained from Olea europaea. Planta Med. 69, 472\u2013474 (2003).","journal-title":"Planta Med."},{"key":"15361_CR60","first-page":"594","volume":"81","author":"H Fouotsa","year":"2015","unstructured":"Fouotsa, H. et al. Antibacterial and antioxidant xanthones and benzophenone from Garcinia smeathmannii. Am. Assoc. Adv. Sci. 81, 594\u2013599 (2015).","journal-title":"Am. Assoc. Adv. Sci."},{"key":"15361_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep37151","volume":"6","author":"A Amin","year":"2016","unstructured":"Amin, A. et al. Irigenin, a novel lead from Western Himalayan chemiome inhibits fibronectin-extra domain A induced metastasis in lung cancer cells. Sci. Rep. 6, 1\u201313 (2016).","journal-title":"Sci. Rep."},{"key":"15361_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109784","volume":"125","author":"L Guo","year":"2020","unstructured":"Guo, L. et al. Irigenin treatment alleviates doxorubicin (DOX)-induced cardiotoxicity by suppressing apoptosis, inflammation and oxidative stress via the increase of miR-425. Biomed. Pharmacother. 125, 109784 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"15361_CR63","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/ddr.21802","volume":"82","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Irigenin alleviates angiotensin II-induced oxidative stress and apoptosis in HUVEC cells by activating Nrf2 pathway. Drug Dev. Res. 82, 999\u20131007 (2021).","journal-title":"Drug Dev. Res."},{"key":"15361_CR64","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.lfs.2005.09.041","volume":"78","author":"KS Ahn","year":"2006","unstructured":"Ahn, K. S. et al. Inhibitory effects of Irigenin from the rhizomes of Belamcanda chinensis on nitric oxide and prostaglandin E2 production in murine macrophage RAW 264.7 cells. Life Sci. 78, 2336\u20132342 (2006).","journal-title":"Life Sci."},{"key":"15361_CR65","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.bbrc.2018.01.003","volume":"496","author":"Y Xu","year":"2018","unstructured":"Xu, Y., Gao, C.-C., Pan, Z.-G. & Zhou, C.-W. Irigenin sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells. Biochem. Biophys. Res. Commun. 496, 998\u20131005 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"15361_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-47746-9","volume":"9","author":"A Gonz\u00e1lez","year":"2019","unstructured":"Gonz\u00e1lez, A. et al. Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA. Sci. Rep. 9, 1\u201313 (2019).","journal-title":"Sci. Rep."},{"key":"15361_CR67","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/ja.2016.36","volume":"69","author":"K Klesiewicz","year":"2016","unstructured":"Klesiewicz, K., Karczewska, E., Budak, A., Marona, H. & Szkaradek, N. Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone. J. Antibiot. 69, 825\u2013834 (2016).","journal-title":"J. Antibiot."},{"key":"15361_CR68","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2174\/157019308786242223","volume":"5","author":"Y-W Chin","year":"2008","unstructured":"Chin, Y.-W. & Kinghorn, A. D. Structural characterization, biological effects, and synthetic studies on xanthones from mangosteen (Garcinia mangostana), a popular botanical dietary supplement. Mini-Rev. Org. Chem. 5, 355\u2013364 (2008).","journal-title":"Mini-Rev. Org. Chem."},{"key":"15361_CR69","doi-asserted-by":"publisher","first-page":"263","DOI":"10.21010\/ajtcam.v14i1.28","volume":"14","author":"Q-J Zhang","year":"2017","unstructured":"Zhang, Q.-J. & Yue, L. Inhibitory activity of mangiferin on Helicobacter pylori-induced inflammation in human gastric carcinoma AGS cells. Afr. J. Tradit. Complement. Altern. Med. 14, 263\u2013271 (2017).","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"key":"15361_CR70","first-page":"303","volume":"5","author":"S Stohs","year":"2018","unstructured":"Stohs, S. et al. A review on antioxidant, anti-inflammatory and gastroprotective abilities of mango (Mangifera indica) leaf extract and mangiferin. J. Nutr. Health Sci 5, 303 (2018).","journal-title":"J. Nutr. Health Sci"},{"key":"15361_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2021.111997","volume":"149","author":"S Mei","year":"2021","unstructured":"Mei, S., Ma, H. & Chen, X. Anticancer and anti-inflammatory properties of mangiferin: A review of its molecular mechanisms. Food Chem. Toxicol. 149, 111997 (2021).","journal-title":"Food Chem. Toxicol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15361-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15361-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15361-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:25:53Z","timestamp":1669357553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15361-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15361"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15361-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"13 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11457"}}